Strong patient growth across all the operating platforms
Continued investments in patient experience and clinical qualities initiatives
Successful completion of Mediclinic and Al Noor Combination and acquisition of 29.9% stake in Spire Healthcare Group
Solid financial performance with stable margins and good cash generation
Revenue growth of 7% with stable margins at 20.3% driving strong underlying earnings growth
Underlying basic earnings per share increased by 3% to 36.7 pence
Proposed final dividend per ordinary share of 5.24 pence
See the reconciliations between the statutory and underlying (non-GAAP) measures.